Clinical trials
Phase 2 Tourette Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 8 |
| 2019 | 2 |
| 2022 | 3 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Recruiting | 4 |
| Terminated | 4 |
| Withdrawn | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurocrine Biosciences | 7 |
| Emalex Biosciences Inc. | 3 |
| Yale University | 3 |
| National Center for Research Resources (NCRR) | 2 |
| Neurothera Labs Inc. | 2 |
| University of Minnesota | 2 |
| Abide Therapeutics | 1 |
| Asarina Pharma | 1 |
| AstraZeneca | 1 |
| Bausch Health Americas, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tourette Syndrome | 39 |
| Tic Disorders | 7 |
| Tics | 6 |
| Anxiety Disorders | 2 |
| Autistic Disorder | 2 |
| Mental Disorders | 2 |
| Neurologic Manifestations | 2 |
| Obsessive-Compulsive Disorder | 2 |
| Rare Diseases | 2 |
| 22q11 Deletion Syndrome | 1 |
Trials
Showing 26 to 39 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.